nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—polycystic ovary syndrome	0.811	1	CbGaD
Ofloxacin—Function kidney decreased—Metformin—polycystic ovary syndrome	0.00789	0.0856	CcSEcCtD
Ofloxacin—CYP1A2—urine—polycystic ovary syndrome	0.00394	0.103	CbGeAlD
Ofloxacin—Acidosis—Metformin—polycystic ovary syndrome	0.00311	0.0338	CcSEcCtD
Ofloxacin—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00293	0.0318	CcSEcCtD
Ofloxacin—Respiratory distress—Metformin—polycystic ovary syndrome	0.00271	0.0294	CcSEcCtD
Ofloxacin—Heartburn—Metformin—polycystic ovary syndrome	0.0025	0.0272	CcSEcCtD
Ofloxacin—Fungal infection—Metformin—polycystic ovary syndrome	0.00223	0.0242	CcSEcCtD
Ofloxacin—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00213	0.0231	CcSEcCtD
Ofloxacin—Rigors—Metformin—polycystic ovary syndrome	0.00211	0.0229	CcSEcCtD
Ofloxacin—Contusion—Metformin—polycystic ovary syndrome	0.00197	0.0214	CcSEcCtD
Ofloxacin—TOP2A—endometrium—polycystic ovary syndrome	0.00194	0.0509	CbGeAlD
Ofloxacin—Moxifloxacin—TOP2A—polycystic ovary syndrome	0.00184	0.201	CrCbGaD
Ofloxacin—TOP2A—uterus—polycystic ovary syndrome	0.00179	0.0469	CbGeAlD
Ofloxacin—TOP2A—adipose tissue—polycystic ovary syndrome	0.00175	0.0459	CbGeAlD
Ofloxacin—Neuropathy—Metformin—polycystic ovary syndrome	0.00162	0.0176	CcSEcCtD
Ofloxacin—TOP2A—adrenal gland—polycystic ovary syndrome	0.00157	0.0412	CbGeAlD
Ofloxacin—SLC22A4—endometrium—polycystic ovary syndrome	0.00155	0.0408	CbGeAlD
Ofloxacin—Lightheadedness—Metformin—polycystic ovary syndrome	0.00154	0.0167	CcSEcCtD
Ofloxacin—Ear pain—Metformin—polycystic ovary syndrome	0.00147	0.0159	CcSEcCtD
Ofloxacin—TOP2A—female gonad—polycystic ovary syndrome	0.00146	0.0384	CbGeAlD
Ofloxacin—TOP2A—vagina—polycystic ovary syndrome	0.00145	0.0382	CbGeAlD
Ofloxacin—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00141	0.0369	CbGeAlD
Ofloxacin—SLC22A4—adipose tissue—polycystic ovary syndrome	0.0014	0.0367	CbGeAlD
Ofloxacin—Pefloxacin—TOP2A—polycystic ovary syndrome	0.00134	0.147	CrCbGaD
Ofloxacin—Renal impairment—Metformin—polycystic ovary syndrome	0.00131	0.0143	CcSEcCtD
Ofloxacin—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00131	0.0343	CbGeAlD
Ofloxacin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00128	0.0139	CcSEcCtD
Ofloxacin—Enoxacin—TOP2A—polycystic ovary syndrome	0.00126	0.137	CrCbGaD
Ofloxacin—SLC22A4—adrenal gland—polycystic ovary syndrome	0.00126	0.0329	CbGeAlD
Ofloxacin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00125	0.0136	CcSEcCtD
Ofloxacin—Migraine—Metformin—polycystic ovary syndrome	0.00123	0.0134	CcSEcCtD
Ofloxacin—ABCC1—endometrium—polycystic ovary syndrome	0.00117	0.0307	CbGeAlD
Ofloxacin—SLC22A4—vagina—polycystic ovary syndrome	0.00116	0.0305	CbGeAlD
Ofloxacin—Dehydration—Metformin—polycystic ovary syndrome	0.00116	0.0126	CcSEcCtD
Ofloxacin—Sparfloxacin—TOP2A—polycystic ovary syndrome	0.00116	0.126	CrCbGaD
Ofloxacin—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00115	0.0302	CbGeAlD
Ofloxacin—Breast disorder—Metformin—polycystic ovary syndrome	0.00113	0.0123	CcSEcCtD
Ofloxacin—Cramp muscle—Metformin—polycystic ovary syndrome	0.00113	0.0122	CcSEcCtD
Ofloxacin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00112	0.0121	CcSEcCtD
Ofloxacin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00109	0.0118	CcSEcCtD
Ofloxacin—ABCC1—uterus—polycystic ovary syndrome	0.00108	0.0283	CbGeAlD
Ofloxacin—ABCC2—adrenal gland—polycystic ovary syndrome	0.00107	0.0281	CbGeAlD
Ofloxacin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00106	0.0115	CcSEcCtD
Ofloxacin—ABCC1—pituitary gland—polycystic ovary syndrome	0.00106	0.0278	CbGeAlD
Ofloxacin—ABCC1—adipose tissue—polycystic ovary syndrome	0.00105	0.0276	CbGeAlD
Ofloxacin—Sweating increased—Metformin—polycystic ovary syndrome	0.00105	0.0114	CcSEcCtD
Ofloxacin—Angina pectoris—Metformin—polycystic ovary syndrome	0.00105	0.0114	CcSEcCtD
Ofloxacin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00104	0.0112	CcSEcCtD
Ofloxacin—SLC22A5—endometrium—polycystic ovary syndrome	0.00103	0.027	CbGeAlD
Ofloxacin—Neutropenia—Metformin—polycystic ovary syndrome	0.00101	0.011	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.001	0.0109	CcSEcCtD
Ofloxacin—Infestation—Metformin—polycystic ovary syndrome	0.000964	0.0105	CcSEcCtD
Ofloxacin—Drowsiness—Metformin—polycystic ovary syndrome	0.000964	0.0105	CcSEcCtD
Ofloxacin—Infestation NOS—Metformin—polycystic ovary syndrome	0.000964	0.0105	CcSEcCtD
Ofloxacin—Lomefloxacin—TOP2A—polycystic ovary syndrome	0.000952	0.104	CrCbGaD
Ofloxacin—ABCC1—adrenal gland—polycystic ovary syndrome	0.000945	0.0248	CbGeAlD
Ofloxacin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000944	0.0102	CcSEcCtD
Ofloxacin—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00093	0.0244	CbGeAlD
Ofloxacin—ABCC2—endocrine gland—polycystic ovary syndrome	0.00093	0.0244	CbGeAlD
Ofloxacin—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000926	0.0243	CbGeAlD
Ofloxacin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000911	0.00989	CcSEcCtD
Ofloxacin—ABCC1—female gonad—polycystic ovary syndrome	0.000881	0.0231	CbGeAlD
Ofloxacin—Bradycardia—Metformin—polycystic ovary syndrome	0.000881	0.00956	CcSEcCtD
Ofloxacin—ABCC1—vagina—polycystic ovary syndrome	0.000876	0.023	CbGeAlD
Ofloxacin—Rhinitis—Metformin—polycystic ovary syndrome	0.000867	0.00941	CcSEcCtD
Ofloxacin—Hepatitis—Metformin—polycystic ovary syndrome	0.000865	0.00939	CcSEcCtD
Ofloxacin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000861	0.00934	CcSEcCtD
Ofloxacin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000852	0.00925	CcSEcCtD
Ofloxacin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00085	0.00922	CcSEcCtD
Ofloxacin—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000831	0.0218	CbGeAlD
Ofloxacin—Levofloxacin—TOP2A—polycystic ovary syndrome	0.000814	0.0888	CrCbGaD
Ofloxacin—Eye disorder—Metformin—polycystic ovary syndrome	0.000808	0.00877	CcSEcCtD
Ofloxacin—Flushing—Metformin—polycystic ovary syndrome	0.000803	0.00871	CcSEcCtD
Ofloxacin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000803	0.00871	CcSEcCtD
Ofloxacin—Ciprofloxacin—TOP2A—polycystic ovary syndrome	0.000786	0.0858	CrCbGaD
Ofloxacin—Angiopathy—Metformin—polycystic ovary syndrome	0.000785	0.00852	CcSEcCtD
Ofloxacin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000781	0.00848	CcSEcCtD
Ofloxacin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00078	0.00846	CcSEcCtD
Ofloxacin—Chills—Metformin—polycystic ovary syndrome	0.000776	0.00842	CcSEcCtD
Ofloxacin—SLC22A5—female gonad—polycystic ovary syndrome	0.000775	0.0203	CbGeAlD
Ofloxacin—SLC22A5—vagina—polycystic ovary syndrome	0.00077	0.0202	CbGeAlD
Ofloxacin—Erythema—Metformin—polycystic ovary syndrome	0.000753	0.00817	CcSEcCtD
Ofloxacin—Malnutrition—Metformin—polycystic ovary syndrome	0.000753	0.00817	CcSEcCtD
Ofloxacin—Flatulence—Metformin—polycystic ovary syndrome	0.000742	0.00805	CcSEcCtD
Ofloxacin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000737	0.008	CcSEcCtD
Ofloxacin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000724	0.00786	CcSEcCtD
Ofloxacin—Vision blurred—Metformin—polycystic ovary syndrome	0.00071	0.0077	CcSEcCtD
Ofloxacin—Tremor—Metformin—polycystic ovary syndrome	0.000705	0.00766	CcSEcCtD
Ofloxacin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000699	0.00758	CcSEcCtD
Ofloxacin—Malaise—Metformin—polycystic ovary syndrome	0.000679	0.00737	CcSEcCtD
Ofloxacin—Syncope—Metformin—polycystic ovary syndrome	0.000675	0.00733	CcSEcCtD
Ofloxacin—Palpitations—Metformin—polycystic ovary syndrome	0.000665	0.00722	CcSEcCtD
Ofloxacin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000662	0.00718	CcSEcCtD
Ofloxacin—Norfloxacin—TOP2A—polycystic ovary syndrome	0.00066	0.072	CrCbGaD
Ofloxacin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000653	0.0171	CbGeAlD
Ofloxacin—Hypertension—Metformin—polycystic ovary syndrome	0.00065	0.00705	CcSEcCtD
Ofloxacin—Chest pain—Metformin—polycystic ovary syndrome	0.000641	0.00696	CcSEcCtD
Ofloxacin—Myalgia—Metformin—polycystic ovary syndrome	0.000641	0.00696	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000637	0.00691	CcSEcCtD
Ofloxacin—Discomfort—Metformin—polycystic ovary syndrome	0.000633	0.00687	CcSEcCtD
Ofloxacin—Oedema—Metformin—polycystic ovary syndrome	0.000615	0.00667	CcSEcCtD
Ofloxacin—Infection—Metformin—polycystic ovary syndrome	0.000611	0.00663	CcSEcCtD
Ofloxacin—Shock—Metformin—polycystic ovary syndrome	0.000605	0.00656	CcSEcCtD
Ofloxacin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000603	0.00654	CcSEcCtD
Ofloxacin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000602	0.00653	CcSEcCtD
Ofloxacin—Skin disorder—Metformin—polycystic ovary syndrome	0.000597	0.00648	CcSEcCtD
Ofloxacin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000594	0.00645	CcSEcCtD
Ofloxacin—Anorexia—Metformin—polycystic ovary syndrome	0.000586	0.00636	CcSEcCtD
Ofloxacin—Hypotension—Metformin—polycystic ovary syndrome	0.000574	0.00623	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00056	0.00608	CcSEcCtD
Ofloxacin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000552	0.00599	CcSEcCtD
Ofloxacin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000548	0.00595	CcSEcCtD
Ofloxacin—Somnolence—Metformin—polycystic ovary syndrome	0.000546	0.00593	CcSEcCtD
Ofloxacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000541	0.00587	CcSEcCtD
Ofloxacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000534	0.0058	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000531	0.00576	CcSEcCtD
Ofloxacin—Fatigue—Metformin—polycystic ovary syndrome	0.00053	0.00575	CcSEcCtD
Ofloxacin—Constipation—Metformin—polycystic ovary syndrome	0.000526	0.0057	CcSEcCtD
Ofloxacin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000506	0.0055	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000503	0.00545	CcSEcCtD
Ofloxacin—Urticaria—Metformin—polycystic ovary syndrome	0.000488	0.0053	CcSEcCtD
Ofloxacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000486	0.00527	CcSEcCtD
Ofloxacin—Asthenia—Metformin—polycystic ovary syndrome	0.000441	0.00478	CcSEcCtD
Ofloxacin—Pruritus—Metformin—polycystic ovary syndrome	0.000435	0.00472	CcSEcCtD
Ofloxacin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00042	0.00456	CcSEcCtD
Ofloxacin—Dizziness—Metformin—polycystic ovary syndrome	0.000406	0.00441	CcSEcCtD
Ofloxacin—Vomiting—Metformin—polycystic ovary syndrome	0.000391	0.00424	CcSEcCtD
Ofloxacin—Rash—Metformin—polycystic ovary syndrome	0.000387	0.0042	CcSEcCtD
Ofloxacin—Dermatitis—Metformin—polycystic ovary syndrome	0.000387	0.0042	CcSEcCtD
Ofloxacin—Headache—Metformin—polycystic ovary syndrome	0.000385	0.00418	CcSEcCtD
Ofloxacin—Nausea—Metformin—polycystic ovary syndrome	0.000365	0.00396	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000354	0.00713	CbGpPWpGaD
Ofloxacin—Norfloxacin—CYP1A1—polycystic ovary syndrome	0.000353	0.0385	CrCbGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000343	0.0069	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000318	0.00641	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000295	0.00594	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000293	0.0059	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00029	0.00584	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000287	0.00578	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000284	0.00572	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000277	0.00558	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000275	0.00555	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000272	0.00548	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.000269	0.00541	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000264	0.00533	CbGpPWpGaD
Ofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00025	0.00503	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000248	0.00499	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000246	0.00496	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000245	0.00494	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000241	0.00486	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000227	0.00458	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000217	0.00436	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000215	0.00432	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000214	0.00432	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00021	0.00423	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.00021	0.00422	CbGpPWpGaD
Ofloxacin—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000209	0.00421	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000207	0.00418	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000204	0.00412	CbGpPWpGaD
Ofloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000201	0.00405	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000185	0.00373	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000181	0.00365	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000178	0.00358	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000175	0.00353	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000172	0.00346	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00017	0.00343	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00016	0.00322	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000159	0.00321	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000159	0.0032	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000158	0.00319	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000158	0.00318	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000155	0.00313	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000154	0.00311	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00015	0.00302	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00015	0.00301	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000149	0.00301	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000148	0.00298	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000146	0.00295	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000144	0.00291	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000142	0.00286	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000141	0.00283	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000141	0.00283	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00014	0.00281	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000137	0.00276	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000136	0.00274	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000135	0.00272	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000134	0.00271	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000134	0.00271	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000134	0.00269	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000134	0.00269	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000133	0.00268	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000132	0.00267	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000129	0.0026	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000122	0.00245	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000119	0.00239	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000118	0.00237	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000118	0.00237	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000117	0.00235	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000112	0.00225	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00011	0.00222	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00011	0.00222	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.00011	0.00222	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000109	0.00219	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000108	0.00217	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000107	0.00216	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000107	0.00216	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000107	0.00216	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000107	0.00215	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000106	0.00214	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000104	0.0021	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NMNAT3—polycystic ovary syndrome	0.000103	0.00208	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000103	0.00208	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000103	0.00207	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000102	0.00206	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.0001	0.00202	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	9.85e-05	0.00199	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	9.75e-05	0.00196	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	9.55e-05	0.00192	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	9.49e-05	0.00191	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	9.38e-05	0.00189	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	9.16e-05	0.00185	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	9.06e-05	0.00182	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	8.84e-05	0.00178	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	8.73e-05	0.00176	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.73e-05	0.00176	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.68e-05	0.00175	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NMNAT3—polycystic ovary syndrome	8.66e-05	0.00174	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.57e-05	0.00173	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	8.55e-05	0.00172	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	8.26e-05	0.00166	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.19e-05	0.00165	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	8.07e-05	0.00163	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LPCAT2—polycystic ovary syndrome	7.92e-05	0.0016	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SUOX—polycystic ovary syndrome	7.92e-05	0.0016	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	7.91e-05	0.00159	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.82e-05	0.00157	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.72e-05	0.00155	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.63e-05	0.00154	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ISYNA1—polycystic ovary syndrome	7.36e-05	0.00148	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.33e-05	0.00148	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	7.19e-05	0.00145	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.17e-05	0.00145	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	7.12e-05	0.00143	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	7.04e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	7.02e-05	0.00141	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	6.75e-05	0.00136	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.72e-05	0.00135	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.56e-05	0.00132	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.47e-05	0.0013	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.37e-05	0.00128	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	6.3e-05	0.00127	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKR1C2—polycystic ovary syndrome	6.26e-05	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TEAD2—polycystic ovary syndrome	6.26e-05	0.00126	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	6.22e-05	0.00125	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.13e-05	0.00123	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.02e-05	0.00121	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.92e-05	0.00119	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.87e-05	0.00118	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.86e-05	0.00118	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.83e-05	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.78e-05	0.00116	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.64e-05	0.00114	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.58e-05	0.00112	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.51e-05	0.00111	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.42e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	5.34e-05	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	5.34e-05	0.00108	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RPL37A—polycystic ovary syndrome	5.33e-05	0.00107	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.25e-05	0.00106	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.25e-05	0.00106	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	5.24e-05	0.00106	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.18e-05	0.00104	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HMMR—polycystic ovary syndrome	5.05e-05	0.00102	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	5.03e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	4.97e-05	0.001	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.95e-05	0.000998	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.8e-05	0.000967	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—STAR—polycystic ovary syndrome	4.74e-05	0.000956	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.74e-05	0.000955	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.69e-05	0.000945	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.64e-05	0.000934	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.57e-05	0.000921	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	4.47e-05	0.000901	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	4.24e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	4.23e-05	0.000852	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	4.16e-05	0.000837	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.16e-05	0.000837	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.07e-05	0.000819	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	4.05e-05	0.000815	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	4.03e-05	0.000812	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.03e-05	0.000811	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.99e-05	0.000803	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.98e-05	0.000802	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGF18—polycystic ovary syndrome	3.86e-05	0.000777	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RBP4—polycystic ovary syndrome	3.83e-05	0.000771	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.78e-05	0.000761	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.74e-05	0.000753	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.69e-05	0.000743	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LHB—polycystic ovary syndrome	3.68e-05	0.000741	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	3.59e-05	0.000724	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GAB1—polycystic ovary syndrome	3.52e-05	0.00071	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	3.48e-05	0.000701	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	3.44e-05	0.000693	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NAMPT—polycystic ovary syndrome	3.43e-05	0.000691	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	3.29e-05	0.000662	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	3.2e-05	0.000645	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	3.2e-05	0.000645	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	3.15e-05	0.000635	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.14e-05	0.000632	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	3.1e-05	0.000625	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	3.07e-05	0.000618	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	3.01e-05	0.000606	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	3.01e-05	0.000606	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	2.99e-05	0.000603	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.97e-05	0.000598	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	2.87e-05	0.000579	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.86e-05	0.000576	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	2.84e-05	0.000572	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.82e-05	0.000568	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.8e-05	0.000563	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	2.79e-05	0.000561	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.73e-05	0.00055	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	2.7e-05	0.000543	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	2.68e-05	0.00054	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	2.65e-05	0.000534	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	2.64e-05	0.000532	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.55e-05	0.000514	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRL—polycystic ovary syndrome	2.53e-05	0.00051	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.42e-05	0.000488	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.38e-05	0.000479	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	2.38e-05	0.000479	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.29e-05	0.00046	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TH—polycystic ovary syndrome	2.28e-05	0.00046	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.25e-05	0.000453	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	2.22e-05	0.000447	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NCOR1—polycystic ovary syndrome	2.12e-05	0.000427	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	2.09e-05	0.000421	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRG1—polycystic ovary syndrome	2.08e-05	0.000419	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.99e-05	0.000401	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.89e-05	0.00038	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—polycystic ovary syndrome	1.87e-05	0.000377	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	1.86e-05	0.000375	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.8e-05	0.000363	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IRS2—polycystic ovary syndrome	1.78e-05	0.000359	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.78e-05	0.000359	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	1.78e-05	0.000358	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1.68e-05	0.000339	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.61e-05	0.000323	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	1.57e-05	0.000316	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IRS1—polycystic ovary syndrome	1.56e-05	0.000313	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.53e-05	0.000309	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.51e-05	0.000305	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—INS—polycystic ovary syndrome	1.49e-05	0.0003	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT2—polycystic ovary syndrome	1.44e-05	0.00029	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.44e-05	0.000289	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.4e-05	0.000281	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	1.37e-05	0.000276	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.37e-05	0.000275	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.32e-05	0.000266	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	1.27e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	0.000253	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—INS—polycystic ovary syndrome	1.25e-05	0.000251	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.22e-05	0.000245	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.18e-05	0.000237	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.14e-05	0.000229	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.09e-05	0.00022	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.09e-05	0.000219	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.08e-05	0.000217	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.07e-05	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.02e-05	0.000205	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1e-05	0.000202	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	8.67e-06	0.000175	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.43e-06	0.00017	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.93e-06	0.00016	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	7.08e-06	0.000143	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.74e-06	0.000136	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—polycystic ovary syndrome	6.51e-06	0.000131	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.39e-06	0.000129	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.96e-06	0.00012	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.83e-06	9.73e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.77e-06	9.6e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.74e-06	9.55e-05	CbGpPWpGaD
